Transport and retention of biogenic selenium nanoparticles in biofilm-coated quartz sand porous media and consequence for elemental mercury immobilization

Bacterial biofilms are structured cell communities embedded in a matrix of extracellular polymeric substances (EPS) and a ubiquitous growth form of bacteria in the environment. A wide range of interactions between biofilms and nanoparticles have been reported. In the present study, the influence of a mixed bacterial biofilm on retention of biogenic selenium nanoparticles (BioSeNPs) and consequences for immobilization of elemental mercury (Hg⁰) in a porous quartz sand system were examined. BioSeNPs were significantly retained in the presence of a biofilm through electrical double layer effects, hydrogen bonding, and hydrophobic, steric and bridging interactions. Moreover, enhanced surface roughness, pore clogging, sieving and entrapment effects mediated by the biofilm also contributed to deposition of BioSeNPs. Whereas, thiol groups associated with the biofilm is a little helpful for the capture of Hg⁰. It is proposed that oxidative complexation between Hg⁰ and thiol compounds or S containing organic matter in the biofilm may result in the formation of Hg²⁺-thiolate complexes and HgS during the binding of Hg⁰ with BioSeNPs. The formation of mercury selenide was also involved in Hg⁰ immobilization in the porous quartz sand system.

Conjugation of pH-responsive nanoparticles to neural stem cells improves intratumoral therapy

Intratumoral drug delivery is an inherently appealing approach for concentrating toxic chemotherapies at the site of action. This mode of administration is currently used in a number of clinical treatments such as neoadjuvant, adjuvant, and even standalone therapies when radiation and surgery are not possible. However, even when injected locally, it is difficult to achieve efficient distribution of chemotherapeutics throughout the tumor. This is primarily attributed to the high interstitial pressure which results in gradients that drive fluid away from the tumor center. The stiff extracellular matrix also limits drug penetration throughout the tumor. We have previously shown that neural stem cells can penetrate tumor interstitium, actively migrating even to hypoxic tumor cores. When used to deliver therapeutics, these migratory neural stem cells result in dramatically enhanced tumor coverage relative to conventional delivery approaches. We recently showed that neural stem cells maintain their tumor tropic properties when surface-conjugated to nanoparticles. Here we demonstrate that this hybrid delivery system can be used to improve the efficacy of docetaxel-loaded nanoparticles when administered intratumorally. This was achieved by conjugating drug-loaded nanoparticles to the surface of neural stem cells using a bond that allows the stem cells to efficiently distribute nanoparticles throughout the tumor before releasing the drug for uptake by tumor cells. The modular nature of this system suggests that it could be used to improve the efficacy of many chemotherapy drugs after intratumoral administration.

Matrigel alters the pathophysiology of orthotopic human breast adenocarcinoma xenografts with implications for nanomedicine evaluation

Matrigel, a mouse sarcoma-derived basement membrane protein mixture, is frequently used to facilitate human tumor xenograft growth in rodents. Despite its known effects on tumor growth and metastasis, its impact on tumor pathophysiology and preclinical evaluation of nanomedicines in tumor xenografts has not been reported previously. Herein bilateral MDA435 tumors were established orthotopically with (Mat+) or without (Mat-) co-injection of Matrigel. Tumor perfusion, morphology and nanoparticle retention were evaluated. As compared to Mat- tumors, Mat+tumors exhibited enhanced vascular perfusion and lymphatic flow, greater blood vessel and lymphatic growth within the tumor core, and more deformation and collapse of lymphatics in tumor-associated lymph nodes. These changes were accompanied by reduced nanoparticle retention in Mat+tumors. The results suggest that Matrigel is not a passive medium for tumor growth, but rather significantly alters long-term tumor architecture. These findings have significant implications for the evaluation of therapeutic nanomedicine in xenograft mouse models.

FROM THE CLINICAL EDITOR

Matrigel is utilized in facilitating human tumor xenograft growth in rodents. The authors demonstrate that Matrigel is not a passive medium for tumor growth; instead it significantly alters long-term tumor architecture, with major implications in the evaluation of therapeutic nanomedicine in xenograft mouse models.